Vasoactive intestinal peptide‐induced tolerogenic dendritic cells attenuated arthritis in experimental collagen‐induced arthritic mice

Abstract

Cumulative evidence has revealed that tolerogenic dendritic cells (tolDC) could relieve inflammation reactions in various autoimmune diseases. This study investigated the potential therapeutic application of vasoactive intestinal peptide (VIP)‐induced tolDC (VIP‐DC) on arthritis using collagen‐induced arthritis (CIA) mice.